Today, Jefferies Group Reiterates $9.00 Price Target for Corium International Inc. (CORI)

Today, Jefferies Group Reiterates $9.00 Price Target for Corium International Inc. (CORI)

Jefferies Group set a $9.00 target price on Corium International Inc. (NASDAQ:CORI) in a report published on Thursday. The firm currently has a buy rating on the biopharmaceutical company’s stock.

CORI has been the subject of a number of other reports. Needham & Company LLC restated a buy rating and issued a $15.00 target price on shares of Corium International in a report on Monday, September 26th. Zacks Investment Research downgraded shares of Corium International from a hold rating to a sell rating in a report on Tuesday, October 11th. Leerink Swann set a $16.00 target price on shares of Corium International and gave the company a buy rating in a report on Tuesday, November 22nd. Finally, FBR & Co restated a buy rating and issued a $18.00 target price on shares of Corium International in a report on Tuesday, November 22nd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of Buy and a consensus target price of $12.25.

Shares of Corium International (NASDAQ:CORI) opened at 5.43 on Thursday. The company’s 50-day moving average is $5.02 and its 200 day moving average is $4.76. Corium International has a 52 week low of $3.14 and a 52 week high of $9.93. The firm’s market capitalization is $120.58 million.

A number of large investors have recently added to or reduced their stakes in CORI. Paloma Partners Management Co acquired a new stake in Corium International during the second quarter valued at about $152,000. Opaleye Management Inc. increased its position in shares of Corium International by 1.4% in the first quarter. Opaleye Management Inc. now owns 360,000 shares of the biopharmaceutical company’s stock valued at $1,390,000 after buying an additional 5,000 shares during the period. Finally, RTW Investments LLC increased its position in shares of Corium International by 3.0% in the second quarter. RTW Investments LLC now owns 852,961 shares of the biopharmaceutical company’s stock valued at $2,960,000 after buying an additional 24,629 shares during the period. Institutional investors own 88.40% of the company’s stock.

About Corium International

Related posts

Leave a Comment